However, its cell-type distribution and clinical relevance in breast cancer remain incompletely defined.<h4>Methods</h4>We integrated 26 scRNA-seq samples spanning ER+, HER2+, and triple-negative breast cancer (TNBC), comprising 98,572 cells. This evidence concerns the gene ERBB2 and breast cancer.